Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase

Cardiovascular Research

Volumn 111, Issue 1, 2016, Pages 34-43

  Massengill, Michael T ^a   Ashraf, Hassan M ^a   Chowdhury, Rajib R ^a   Chrzanowski, Stephen M ^a   Kar, Jeena ^a   Warren, Sonisha A ^a   Walter, Glenn A ^a   Zeng, Huadong ^b   Kang, Byung Ho ^b   Anderson, Robert H ^c   Moss, Richard L ^d   Kasahara, Hideko ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Heart failure; Inducible knockout; Kinase

Indexed keywords

CARDIAC MYOSIN; MESSENGER RNA; MYOSIN LIGHT CHAIN 2; MYOSIN LIGHT CHAIN KINASE; PHOSPHOLAMBAN; TAMOXIFEN; CARDIAC MYOSIN LIGHT CHAIN KINASE, MOUSE; MYOSIN LIGHT CHAIN;

ACUTE HEART FAILURE; ADULT; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CONTROLLED STUDY; DETERIORATION; ENZYME ACTIVE SITE; EXON; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; KNOCKOUT MOUSE; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REDUCTION (CHEMISTRY); ACUTE DISEASE; ADAPTATION; ANIMAL; ATROPHY; C57BL MOUSE; CALCIUM SIGNALING; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHOSPHORYLATION; SARCOMERE; TIME FACTOR;

ACUTE DISEASE; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ATROPHY; CALCIUM SIGNALING; CARDIAC MYOSINS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HEART FAILURE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHENOTYPE; PHOSPHORYLATION; SARCOMERES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 85007047104     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw069     Document Type: Article

References (47)

1. Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M. Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer 2010;10:105.
2. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
3. Diwan A, Dorn GW II. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007;22:56-64.
4. Balasubramanian S, Johnston RK, Moschella PC, Mani SK, Tuxworth WJ Jr, Kuppuswamy D. mTOR in growth and protection of hypertrophying myocardium. Cardiovasc Hematol Agents Med Chem 2009;7:52-63.
5. Russell B, Curtis MW, Koshman YE, Samarel AM. Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J Mol Cell Cardiol 2010;48: 817-823.
6. Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol 2013;55:31-41.
7. Sanbe A, Fewell JG, Gulick J, Osinska H, Lorenz J, Hall DG, Murray LA, Kimball TR, Witt SA, Robbins J. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem 1999;274: 21085-21094.
8. Davis JS, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H, Epstein ND. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell 2001;107:631-641.
9. Moss RL, Fitzsimons DP. Myosin light chain 2 into the mainstream of cardiac development and contractility. Circ Res 2006;99:225-227.
10. Stelzer JE, Patel JR, Moss RL. Acceleration of stretch activation in murine myocardium due to phosphorylation of myosin regulatory light chain. J Gen Physiol 2006;128: 261-272.
11. Scruggs SB, Solaro RJ. The significance of regulatory light chain phosphorylation in cardiac physiology. Arch Biochem Biophys 2011;510:129-134.
12. Sheikh F, Ouyang K, Campbell SG, Lyon RC, Chuang J, Fitzsimons D, Tangney J, Hidalgo CG, Chung CS, Cheng H, Dalton ND, Gu Y, Kasahara H, Ghassemian M, Omens JH, Peterson KL, Granzier HL, Moss RL, McCulloch AD, Chen J. Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. J Clin Invest 2012;122:1209-1221.
13. Sheikh F, Lyon RC, Chen J. Getting the skinny on thick filament regulation in cardiac muscle biology and disease. Trends Cardiovasc Med 2013;24:133-141.
14. Seguchi O, Takashima S, Yamazaki S, Asakura M, Asano Y, Shintani Y, Wakeno M, Minamino T, Kondo H, Furukawa H, Nakamaru K, Naito A, Takahashi T, Ohtsuka T, Kawakami K, Isomura T, Kitamura S, Tomoike H, Mochizuki N, Kitakaze M. A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest 2007;117:2812-2824.
15. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, Horikoshi N, Weinberg EO, Aoki H, Sato N, Chien KR, Kasahara H. Identification of cardiac-specific myosin light chain kinase. Circ Res 2008;102:571-580.
16. Ding P, Huang J, Battiprolu PK, Hill JA, Kamm KE, Stull JT. Cardiac myosin light chain kinase is necessary for myosin regulatory light chain phosphorylation and cardiac performance in vivo. J Biol Chem 2010;285:40819-40829.
17. Warren SA, Briggs LE, Zeng H, Chuang J, Chang EI, Terada R, Li M, Swanson MS, Lecker SH, Willis MS, Spinale FG, Maupin-Furlowe J, McMullen JR, Moss RL, Kasahara H. Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 2012;126:2575-2588.
18. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 2001;89:20-25.
19. Warren SA, Terada R, Briggs LE, Cole-Jeffrey CT, Chien WM, Seki T, Weinberg EO, Yang TP, Chin MT, Bungert J, Kasahara H. Differential role of Nkx2-5 in activation of the atrial natriuretic factor gene in the developing versus failing heart. Mol Cell Biol 2011;31:4633-4645.
20. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008;3:1422-1434.
21. Takeda M, Briggs LE, Wakimoto H, Marks MH, Warren SA, Lu JT, Weinberg EO, Robertson KD, Chien KR, Kasahara H. Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation. Lab Invest 2009;89:983-993.
22. Conti E, Izaurralde E. Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr Opin Cell Biol 2005;17:316-325.
23. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 2009;105:12-15.
24. Ather S, Respress JL, Li N, Wehrens XH. Alterations in ryanodine receptors and related proteins in heart failure. Biochim Biophys Acta 2013;1832:2425-2431.
25. Wittmann T, Lohse MJ, Schmitt JP. Phospholamban pentamers attenuate PKAdependent phosphorylation of monomers. J Mol Cell Cardiol 2015;80:90-97.
26. Herring BP, Dixon S, Gallagher PJ. Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. Am J Physiol Cell Physiol 2000;279:C1656-C1664.
27. Chang AN, Chen G, Gerard RD, Kamm KE, Stull JT. Cardiac myosin is a substrate for zipper-interacting protein kinase (ZIPK). J Biol Chem 2010;285:5122-5126.
28. Morano I. Tuning the human heart molecular motors by myosin light chains. J Mol Med 1999;77:544-555.
29. 2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc Res 2003;57: 505-514.
30. Eichbaum FW. 'Wavy' myocardial fibers in spontaneous and experimental adrenergic cardiopathies. Cardiology 1975;60:358-365.
31. Davies MJ. The cardiomyopathies: a review of terminology, pathology and pathogenesis. Histopathology 1984;8:363-393.
32. Tidholm A, Jonsson L. Histologic characterization of canine dilated cardiomyopathy. Vet Pathol 2005;42:1-8.
33. Chiu YT, Cheng CC, Lin NN, Hung YW, Chen YT, Hsu SL, Chi CS, Fu YC. High-dose norepinephrine induces disruption of myocardial extracellular matrix and left ventricular dilatation and dysfunction in a novel feline model. J Chin Med Assoc 2006;69: 343-350.
34. Kakimoto Y, Ito S, Abiru H, Kotani H, Ozeki M, Tamaki K, Tsuruyama T. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: proteomic analysis of cardiac tissues from patients. J Am Heart Assoc 2013;2:e000565.
35. Lobo L, Carvalheira J, Canada N, Bussadori C, Gomes JL, Faustino AM. Histologic characterization of dilated cardiomyopathy in Estrela mountain dogs. Vet Pathol 2010;47: 637-642.
36. Houser SR, Piacentino V III, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 2000;32:1595-1607.
37. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
38. Mattiazzi A, Bassani RA, Escobar AL, Palomeque J, Valverde CA, Vila Petroff M, Bers DM. Chasing cardiac physiology and pathology down the CaMKII cascade. Am J Physiol Heart Circ Physiol 2015;308:H1177-H1191.
39. Vlasblom R, Muller A, Musters RJ, Zuidwijk MJ, Van Hardeveld C, Paulus WJ, Simonides WS. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc Res 2004;63: 537-544.
40. 2+-ATPase and calsequestrin gene expression in the heart. Can J Physiol Pharmacol 2012;90:1017-1028.
41. Heineke J, Ritter O. Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond. J Mol Cell Cardiol 2012;52:62-73.
42. Periasamy M, Huke S. SERCA pump level is a critical determinant of Ca(2+) homeostasis and cardiac contractility. J Mol Cell Cardiol 2001;33:1053-1063.
43. Soderling TR, Stull JT. Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev 2001;101:2341-2352.
44. Poperechnaya A, Varlamova O, Lin PJ, Stull JT, Bresnick AR. Localization and activity of myosin light chain kinase isoforms during the cell cycle. J Cell Biol 2000;151:697-708.
45. Chen C, Tao T, Wen C, He WQ, Qiao YN, Gao YQ, Chen X, Wang P, Chen CP, Zhao W, Chen HQ, Ye AP, Peng YJ, Zhu MS. Myosin light chain kinase (MLCK) regulates cell migration in a myosin regulatory light chain phosphorylation-independent mechanism. J Biol Chem 2014;101:2341-2352.
46. Hall ME, Smith G, Hall JE, Stec DE. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol 2011;301: H253-H260.
47. Chang AN, Battiprolu PK, Cowley PM, Chen G, Gerard RD, Pinto JR, Hill JA, Baker AJ, Kamm KE, Stull JT. Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo. J Biol Chem 2015;290:10703-10716.